This page shows the latest Tiziana Life Sciences news and features for those working in and with pharma, biotech and healthcare.
Tiziana Life Sciences has announced that it is initiating a programme to develop its intranasal foralumab to treat or prevent type 1 diabetes. ... Earlier this month, Tiziana also announced plans to investigate intranasal foralumab for the treatment of
Tiziana Life Sciences (Tiziana) has announced that the second patient with non-active secondary progressive multiple sclerosis (SPMS) receiving intranasal foralumab has shown ‘additional clinical improvement’ after 11 months of treatment.
Tiziana Life Sciences (Tiziana) has completed the enrolment of the first patient cohort in its intermediate size patient population expanded access programme to evaluate foralumab in non-active Secondary Progressive Multiple ... Tiziana said that on 12
Tiziana Life Sciences (Tiziana) has announced the start of enrolment of the first patient cohort in its intermediate size patient population expanded access programme to evaluate foralumab in non-active secondary ... Tiziana's Scientific Advisory Board,
Tiziana Life Sciences (Tiziana) has announced that the second patient with non-active secondary progressive multiple sclerosis (SPMS) has shown ‘continued clinical improvement’ after six months of dosing with intranasal Foralumab. ... Based on these
Tiziana Life Sciences (Tiziana) has announced that the Ann Romney Center for Neurologic Diseases at the Brigham and Women’s hospital (BWH) will receive a grant to study the use of ... Gabriele Cerrone, executive chairman and interim chief executive
More from news
Approximately 6 fully matching, plus 1 partially matching documents found.
Kunwar Shailubhai on why biotech is a roller coaster and how Tiziana Life Sciences is pursuing its mission to tackle unmet needs. ... At 58 years old, he is still shuttling between the US and the UK as the London-based company, Tiziana Life Sciences,
More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.
London, UK-based biotechnology group Tiziana Life Sciences has appointed its non-executive director Dr Kunwar Shailubhai as chief executive officer and chief scientific officer. ... He said: “This is a crucial time to be taking on this new role with
Dr Robert Evans joins the UK biotechnology firm. London-based Tiziana Life Sciences has appointed Dr Robert Evans as its new vice president of clinical sciences. ... James Tripp, chief operating officer at Tiziana Life Sciences, said: “Bob's extensive
More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.
No results were found
Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys...